Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishnu Murthy

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaAndrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Scientific Reports|February 16, 2026
Monitoring insecticide resistance in cotton leafhopper in relation to enzymatic activity in major cotton growing areas of central IndiaV Chinna Babu Naik, Lingutla Rajesh Chowdary, G Nagaharish, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 30, 2023
PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective StudyMasatoshi Hotta, Andrei Gafita, Vishnu Murthy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
PSMA PET/CT-Derived Indicators and Outcomes After [<sup>177</sup>Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access ProgramKoichiro Kimura, Vishnu Murthy, Andrew F Voter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2025
Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [<sup>177</sup>Lu]Lu-PSMA-617: A Single-Center Retrospective StudyVishnu Murthy, Koichiro Kimura, Lela Theus, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical ProstatectomyJohn Nikitas, Clayton P Smith, Wesley R Armstrong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical TrialWolfgang P Fendler, Justin Ferdinandus, Johannes Czernin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 26, 2024
Efficacy and Toxicity of [<sup>177</sup>Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION DataVishnu Murthy, Andrew F Voter, Kathleen Nguyen, et al.
JAMA Oncology|September 16, 2021
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialThomas A Hope, Matthias Eiber, Wesley R Armstrong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2023
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate CancerLisa M Gudenkauf, Melody N Chavez, Melinda Leigh Maconi, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaAndrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Scientific Reports|February 16, 2026
Monitoring insecticide resistance in cotton leafhopper in relation to enzymatic activity in major cotton growing areas of central IndiaV Chinna Babu Naik, Lingutla Rajesh Chowdary, G Nagaharish, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 30, 2023
PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective StudyMasatoshi Hotta, Andrei Gafita, Vishnu Murthy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
PSMA PET/CT-Derived Indicators and Outcomes After [<sup>177</sup>Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access ProgramKoichiro Kimura, Vishnu Murthy, Andrew F Voter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 4, 2025
Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [<sup>177</sup>Lu]Lu-PSMA-617: A Single-Center Retrospective StudyVishnu Murthy, Koichiro Kimura, Lela Theus, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical ProstatectomyJohn Nikitas, Clayton P Smith, Wesley R Armstrong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical TrialWolfgang P Fendler, Justin Ferdinandus, Johannes Czernin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 26, 2024
Efficacy and Toxicity of [<sup>177</sup>Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION DataVishnu Murthy, Andrew F Voter, Kathleen Nguyen, et al.
JAMA Oncology|September 16, 2021
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialThomas A Hope, Matthias Eiber, Wesley R Armstrong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2023
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate CancerLisa M Gudenkauf, Melody N Chavez, Melinda Leigh Maconi, et al.
Pageof 4